Korea Bio-Gen Co.Ltd (KQ:318000) — Market Cap & Net Worth
Market Cap & Net Worth: Korea Bio-Gen Co.Ltd (318000)
Korea Bio-Gen Co.Ltd (KQ:318000) has a market capitalization of $26.91 Million (₩39.71 Billion) as of May 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24062 globally and #1744 in its home market, demonstrating a 0.55% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Korea Bio-Gen Co.Ltd's stock price ₩4565.00 by its total outstanding shares 8699361 (8.70 Million). Analyse Korea Bio-Gen Co.Ltd (318000) cash conversion ratio to see how efficiently the company converts income to cash.
Korea Bio-Gen Co.Ltd Market Cap History: 2019 to 2026
Korea Bio-Gen Co.Ltd's market capitalization history from 2019 to 2026. Data shows change from $37.99 Million to $26.91 Million (-13.72% CAGR).
Index Memberships
Korea Bio-Gen Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$306.89 Billion | 0.01% | #930 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$306.89 Billion | 0.01% | #930 of 1384 |
Weight: Korea Bio-Gen Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Korea Bio-Gen Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Korea Bio-Gen Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Korea Bio-Gen Co.Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Korea Bio-Gen Co.Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $37.99 Million | $18.53 Billion | -$1.40 Billion | 0.00x | N/A |
| 2020 | $45.80 Million | $19.79 Billion | $3.12 Billion | 0.00x | 0.01x |
| 2021 | $49.13 Million | $27.20 Billion | $4.00 Billion | 0.00x | 0.01x |
| 2022 | $33.30 Million | $24.35 Billion | $3.25 Billion | 0.00x | 0.01x |
| 2023 | $48.05 Million | $21.59 Billion | $4.58 Billion | 0.00x | 0.01x |
| 2024 | $27.59 Million | $24.92 Billion | $3.77 Billion | 0.00x | 0.01x |
Competitor Companies of 318000 by Market Capitalization
Companies near Korea Bio-Gen Co.Ltd in the global market cap rankings as of May 5, 2026.
Key companies related to Korea Bio-Gen Co.Ltd by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #92 globally with a market cap of $210.18 Billion USD.
- Air Liquide SA (PA:AI): Ranked #223 globally with a market cap of $108.00 Billion USD ( €92.38 Billion EUR).
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #231 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #339 globally with a market cap of $76.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #92 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $493.55 |
| #223 | Air Liquide SA | PA:AI | $108.00 Billion | €177.64 |
| #231 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #339 | Sherwin-Williams Co | NYSE:SHW | $76.97 Billion | $310.49 |
Korea Bio-Gen Co.Ltd Historical Marketcap From 2019 to 2026
Between 2019 and today, Korea Bio-Gen Co.Ltd's market cap moved from $37.99 Million to $ 26.91 Million, with a yearly change of -13.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩26.91 Million | +3.75% |
| 2025 | ₩25.94 Million | -5.98% |
| 2024 | ₩27.59 Million | -42.58% |
| 2023 | ₩48.05 Million | +44.28% |
| 2022 | ₩33.30 Million | -32.22% |
| 2021 | ₩49.13 Million | +7.27% |
| 2020 | ₩45.80 Million | +20.55% |
| 2019 | ₩37.99 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of Korea Bio-Gen Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.91 Million USD |
| MoneyControl | $26.91 Million USD |
| MarketWatch | $26.91 Million USD |
| marketcap.company | $26.91 Million USD |
| Reuters | $26.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Korea Bio-Gen Co.Ltd
KBG Corp. produces and supplies a range of fine chemicals in South Korea and internationally. The company offers silicone chemicals, such as functional organosilanes, functional silicone polymers, silicone resins and intermediates, silicone pressure sensitive adhesives, and silicone materials for electronics; specialty chemicals, including polymerization inhibitors; and food additives, as well as… Read more